Edwards Lifesciences praises CMS NCD on transcatheter aortic valve replacement

Jonathan Block

• Edwards Lifesciences (EW) said that an updated CMS national coverage determination will ease patient access to transcatheter aortic valve replacement.
• The NCD states that CMS will now cover TAVR for symptomatic severe aortic valve stenosis (aortic stenosis) without the coverage with evidence

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.